RN7SL208P

Across TCGA pan-cancer cohorts, RN7SL208P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RN7SL208P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RN7SL208P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL208P expression acts as an unfavorable survival marker, although some lineages such as READ and BLCA show a favorable association.

MESO, READ, and HNSC are the cancer types where RN7SL208P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	All	0.282	0.486	<.001	50	view →
READ	DFS	Tertile	IV	1.000	0.368	.002	36	view →
HNSC	DFS	Quartile	All	0.316	0.552	.008	32	view →
BLCA	OS	Quartile	II,III,IV	0.712	0.535	.005	22	view →
LUAD	OS	Quartile	II,III,IV	0.611	0.761	.008	22	view →
SKCM	OS	Tertile	All	0.829	0.891	.002	21	view →
TGCT	DFS	Median	All	0.688	0.903	<.001	18	view →
LUSC	DFS	Median	IV	0.134	0.827	.014	18	view →
STAD	OS	Quartile	IV	0.728	0.164	.029	15	view →
KICH	DFS	Tertile	II,III,IV	0.245	0.916	.001	14	view →
KIRP	OS	Median	IV	0.045	0.523	.024	12	view →
PAAD	DFS	Median	All	0.213	0.374	.012	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RN7SL208P–MESO (OS)

Open the MESO breakdown →